ImmunoPrecise Antibodies Ltd. submitted a 6-K filing on May 12, 2025, confirming their status as a foreign private issuer and indicating upcoming annual reporting under Form 20-F.
AI Assistant
IMMUNOPRECISE ANTIBODIES LTD
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.